Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-Current Debt (2024 - 2025)

Historic Non-Current Debt for bioAffinity Technologies (BIAF) over the last 2 years, with Q3 2025 value amounting to $43658.0.

  • bioAffinity Technologies' Non-Current Debt rose 10138.38% to $43658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $43658.0, marking a year-over-year increase of 10138.38%. This contributed to the annual value of $20180.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, bioAffinity Technologies' Non-Current Debt stood at $43658.0, which was up 10138.38% from $45952.0 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Non-Current Debt high stood at $48156.0 for Q1 2025, and its period low was $20180.0 during Q4 2024.